SMYD2 and neoplasm: In pancreatic ductal adenocarcinoma, SMYD2 promotes tumor formation by promoting the methylation of Lys355 of human mitogen-activated protein kinase activated protein kinase 3 (MAPKAPK3) (Reynoird et al., 2016).